Unveiling the antibiotic resistance pattern in Staphylococcus aureus: A systematic review (2013-2024)

Table 3 Antibiotics reported in 26 studies and their classes

Class of antibiotics	Name of antibiotic	No of studies	Mean	Min	Max
Beta lactam	Penicillin	12	91.77	59.25	100.00
	Amoxicillin	6	75.71	17.64	100.00
	Ampicillin	7	69.85	28.00	100.00
	Cephalexin	1	17.64	17.64	17.64
	Cefazolin	1	17.64	17.64	17.64
	Ceftriaxone	1	6.00	6.00	6.00
	Cefuroxime	2	12.32	7.00	17.64
	Meropenem	0	0.00	0.00	0.00
	Imepenem	0	0.00	0.00	0.00
	Augmentin	0	0.00	0.00	0.00
	Cefoxitin	6	37.53	6.55	83.30
	Cefepime	1	67.25	67.25	67.25
	Methicillin	9	53.96	3.48	100.00
	Piperacillin	2	54.13	36.00	72.25
	Ceftazidime	2	62.98	59.25	66.70
	Cloxacillin	1	52.94	52.94	52.94
	Cefixime	0	0.00	0.00	0.00
	Cephalosporin	0		0.00	0.00
	Oxacillin	5	48.54	4.00	93.33
	Cefotaxime	0	0.00	0.00	0.00
Glycopeptides	Vancomycin	6	46.20	7.00	100.00
	Teicoplanin	3	5.52	0.10	15.00
Tetracycline	Tetracycline	9	32.22	4.80	66.60
	Doxycycline	2	26.59	12.00	41.17
	Minocycline	0		0.00	0.00
Lincosamide	Clindamycin	15	42.58	8.73	91.48
Macrolides	Erythromycin	12	63.62	9.17	100.00
	Azithromycin	4	30.56	8.00	71.00
Fluroquinolones	Ciprofloxacin	16	54.88	6.38	89.20
	Levofloxacin	4	59.63	8.00	86.00
	Ofloxacin	5	67.95	35.29	100.00
	Gatifloxain	2	64.25	52.00	76.50
	Fluoroquinolones	0	0.00	0.00	0.00
	Norfloxacin	2	30.71	29.41	32.00
Aminoglycosides	Netilmycin	2	11.85	6.05	17.64
	Streptomycin	0	0.00	0.00	0.00
	Gentamycin	17	46.76	3.00	86.00
	Amikacin	4	33.94	17.64	73.25
	Tobramycin	2	66.75	47.50	86.00
Rifamycins	Rifampicin	0		0.00	0.00
Oxazolidinones	Linezolid	4	19.60	2.90	37.50
Synthetic	Cotrimoxazole	16	48.46	20.00	81.45
Nitrobenzene ring	Chloramphenicol	3	18.12	8.00	34.10
Lipopeptide	Daptomycin	0	0.00	0.00	0.00
Phosphonic acid	Fosfomycin	0	0.00	0.00	0.00

Number of studies represent the number of research articles (published during 2013 to 2024) reporting resistance in Staphylococcus aureus to the particular drug.